198 related articles for article (PubMed ID: 30181564)
21. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
Valmary S; Danjoux M; Delsol G; Brousset P
Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
[TBL] [Abstract][Full Text] [Related]
22. Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.
Johnson SM; Umakanthan JM; Yuan J; Fedoriw Y; Bociek RG; Kaiser-Rogers K; Sanmann JN; Montgomery ND
Hum Pathol; 2018 Oct; 80():192-200. PubMed ID: 29902576
[TBL] [Abstract][Full Text] [Related]
23. BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
Soslow RA; Zukerberg LR; Harris NL; Warnke RA
Mod Pathol; 1997 Aug; 10(8):810-7. PubMed ID: 9267824
[TBL] [Abstract][Full Text] [Related]
24. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.
Xu X; Zhang L; Wang Y; Zhang Q; Zhang L; Sun B; Zhang Y
Int J Clin Exp Pathol; 2013; 6(4):788-94. PubMed ID: 23573328
[TBL] [Abstract][Full Text] [Related]
25. High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification.
Ok CY; Medeiros LJ
Pathology; 2020 Jan; 52(1):68-77. PubMed ID: 31735344
[TBL] [Abstract][Full Text] [Related]
26. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.
Khanlari M; Medeiros LJ; Lin P; Xu J; You MJ; Tang G; Yin CC; Wang W; Qiu L; Miranda RN; Bueso-Ramos CE; Li S
Mod Pathol; 2022 Mar; 35(3):419-426. PubMed ID: 34608246
[TBL] [Abstract][Full Text] [Related]
27. How Many Tests Does It Take to Diagnose a Triple-Hit B-Lymphoblastic Lymphoma? (Hint, It's A Lot).
Das M; Tsuchiya KD; Bohling SD; Davis B; Hwang S; Gardner RA; Chisholm KM
Pediatr Dev Pathol; 2024; 27(2):193-197. PubMed ID: 38032739
[TBL] [Abstract][Full Text] [Related]
28. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathologic spectrum of mature aggressive B cell lymphomas.
Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Facchetti F; Pileri S; Rosenwald A; Wotherspoon A; Fend F
Virchows Arch; 2017 Oct; 471(4):453-466. PubMed ID: 28844114
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers.
Lucioni M; Berti E; Arcaini L; Croci GA; Maffi A; Klersy C; Goteri G; Tomasini C; Quaglino P; Riboni R; Arra M; Dallera E; Grandi V; Alaibac M; Ramponi A; Rattotti S; Cabras MG; Franceschetti S; Fraternali-Orcioni G; Zerbinati N; Onida F; Ascani S; Fierro MT; Rupoli S; Gambacorta M; Zinzani PL; Pimpinelli N; Santucci M; Paulli M
Cancer Med; 2016 Oct; 5(10):2740-2755. PubMed ID: 27665744
[TBL] [Abstract][Full Text] [Related]
31. Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
Alsuwaidan A; Pirruccello E; Jaso J; Koduru P; Garcia R; Krueger J; Doucet M; Chaudhry R; Fuda F; Chen W
Cytometry B Clin Cytom; 2019 Sep; 96(5):368-374. PubMed ID: 30734478
[TBL] [Abstract][Full Text] [Related]
32. Double-hit B-cell lymphomas.
Aukema SM; Siebert R; Schuuring E; van Imhoff GW; Kluin-Nelemans HC; Boerma EJ; Kluin PM
Blood; 2011 Feb; 117(8):2319-31. PubMed ID: 21119107
[TBL] [Abstract][Full Text] [Related]
33. TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment.
Singh A; Asghar I; Kohler L; Snower D; Hakim H; Lebovic D
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022018. PubMed ID: 35444774
[TBL] [Abstract][Full Text] [Related]
34. Progression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop.
Duffield AS; Dogan A; Amador C; Cook JR; Czader M; Goodlad JR; Nejati R; Xiao W; Happ L; Parker C; Thacker E; Thakkar D; Dave SS; Wasik MA; Ott G
Am J Clin Pathol; 2023 May; 159(6):572-97. PubMed ID: 37167543
[TBL] [Abstract][Full Text] [Related]
35. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
36. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination.
Magro CM; Wang X; Subramaniyam S; Darras N; Mathew S
Am J Dermatopathol; 2014 Apr; 36(4):303-10. PubMed ID: 23907319
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.
Menguy S; Beylot-Barry M; Parrens M; Ledard AP; Frison E; Comoz F; Battistella M; Szablewski V; Balme B; Croue A; Franck F; Ortonne N; Tournier E; Lamant L; Carlotti A; De Muret A; Le Gall F; Lorton MH; Merlio JP; Vergier B
Histopathology; 2019 Jun; 74(7):1067-1080. PubMed ID: 30715765
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
[TBL] [Abstract][Full Text] [Related]
40. Follicular lymphoma transformed to "double-hit" B lymphoblastic lymphoma presenting in the peritoneal fluid.
Kaplan A; Samad A; Dolan MM; Cioc AM; Holman CJ; Schmechel SC; Pambuccian SE
Diagn Cytopathol; 2013 Nov; 41(11):986-90. PubMed ID: 22623514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
